Xin Lang Cai Jing·2025-10-31 05:31Group 1 - The core point of the news is that Selys Medical experienced a stock price increase of 5.24%, reaching 25.10 CNY per share, with a trading volume of 400 million CNY and a turnover rate of 7.74%, resulting in a total market capitalization of 5.275 billion CNY [1] - Selys Medical Technology Group Co., Ltd. is located in Wuhan, Hubei Province, established on February 23, 2004, and listed on October 31, 2016. The company's main business includes centralized marketing and service for medical testing, agency for in vitro diagnostic products, and research, production, and sales of self-developed in vitro diagnostic products [1] - The revenue composition of Selys Medical is as follows: IVD business accounts for 39.91%, SPD business for 38.01%, and pure sales for 22.08% [1] Group 2 - From the perspective of fund holdings, one fund under Caitong Securities Asset Management has a significant position in Selys Medical. The Caitong Asset Management Healthcare Mixed A Fund (018484) held 200,000 shares in the third quarter, representing 5.72% of the fund's net value, ranking as the tenth largest holding [2] - The Caitong Asset Management Healthcare Mixed A Fund (018484) was established on August 3, 2023, with a latest scale of 64.306 million CNY. Year-to-date returns are 26.17%, ranking 3675 out of 8154 in its category; the one-year return is 25.68%, ranking 3563 out of 8046; and since inception, the return is 11.84% [2]